Intrinsic Value of S&P & Nasdaq Contact Us

Intelligent Bio Solutions Inc. INBS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $-36.70 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-6.38 vs est $-36.70 (beat +82.6%). 2025: actual $-20.00 vs est $-12.50 (missed -60%). Analyst accuracy: 0%.

EPS Estimates — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$6.38 vs Est –$36.70 ▲ 475.2% off
2025 Actual –$20.00 vs Est –$12.50 ▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.004B ▼ 35.0% off
2025 Actual $0.003B vs Est $0.012B ▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message